Xtl Biopharmaceuticals (XTLB) Return on Capital Employed [ROCE] (2009 - 2024)
Xtl Biopharmaceuticals' Return on Capital Employed [ROCE] was -42.86% in the year ended Dec 31, 2025, down 19.24 percentage points from -23.62% a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Return on Capital Employed [ROCE] (2009 - 2024) Analysis & Trends
From the year ended Dec 31, 2009 onward, Xtl Biopharmaceuticals has reported Return on Capital Employed [ROCE] for 15 years.
- Return on Capital Employed [ROCE] shows a five-year change of -28.51 percentage points (years ended Dec 2020 to Dec 2025).
- The figure for the year ended Dec 31, 2025 marks the lowest annual Return on Capital Employed [ROCE] since the year ended Dec 31, 2016.
- Per Business Quant data, Return on Capital Employed [ROCE] in earlier years was -23.62% in the year ended Dec 31, 2024 (+1.06 pp), -24.68% in the year ended Dec 31, 2023 (-7.80 pp), -16.87% in the year ended Dec 31, 2022 (+2.67 pp) and -19.54% in the year ended Dec 31, 2021 (-5.19 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Xtl Biopharmaceuticals | 2.03 Bn | 2.03 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -11.55% |
| Jun 30, 2024 | -37.91% |
| Mar 31, 2024 | -28.08% |
| Dec 31, 2023 | -32.71% |
| Sep 30, 2023 | -30.27% |
| Jun 30, 2023 | -28.69% |
| Mar 31, 2023 | -25.11% |
| Dec 31, 2022 | -20.21% |
| Sep 30, 2022 | -18.19% |
| Jun 30, 2022 | -15.80% |
| Mar 31, 2022 | -16.48% |
| Dec 31, 2021 | -18.91% |
| Sep 30, 2021 | -14.91% |
| Mar 31, 2021 | -13.87% |
| Dec 31, 2020 | -15.53% |
| Sep 30, 2020 | -14.80% |
| Jun 30, 2020 | -13.42% |
| Mar 31, 2020 | -12.86% |
| Dec 31, 2019 | -11.20% |
| Sep 30, 2019 | -9.39% |
API Access
Xtl Biopharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();